Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Change in Account Payables: 2020-2024

Historic Change in Account Payables for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$1.2 million.

  • Tango Therapeutics' Change in Account Payables fell 111.29% to -$344,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 270.12%. This contributed to the annual value of -$1.2 million for FY2024, which is 30.56% up from last year.
  • Tango Therapeutics' Change in Account Payables amounted to -$1.2 million in FY2024, which was up 30.56% from -$1.7 million recorded in FY2023.
  • Tango Therapeutics' 5-year Change in Account Payables high stood at $1.2 million for FY2021, and its period low was -$1.7 million during FY2023.
  • Moreover, its 3-year median value for Change in Account Payables was -$1.2 million (2024), whereas its average is -$597,333.
  • Per our database at Business Quant, Tango Therapeutics' Change in Account Payables slumped by 255.42% in 2023 and then surged by 30.56% in 2024.
  • Tango Therapeutics' Change in Account Payables (Yearly) stood at $1.2 million in 2020, then rose by 5.21% to $1.2 million in 2021, then dropped by 10.96% to $1.1 million in 2022, then slumped by 255.42% to -$1.7 million in 2023, then soared by 30.56% to -$1.2 million in 2024.